Vaping eye disease risk is at the center of a major new study suggesting that switching from cigarettes to electronic vapes may not be the harmless trade-off many assume. While smokeless alternatives are often viewed as a healthier choice, the research indicates that people who switch to vapes face a higher risk of serious eye conditions than those who quit nicotine altogether.

What the Study Examined

The findings, published in the American Journal of Ophthalmology, come from researchers at the Korea University College of Medicine in Seoul, South Korea. The team analyzed health data from 179,273 adults drawn from the Korean National Health Insurance Service.

All participants had smoked traditional cigarettes between 2011 and 2012 before quitting by 2018 or 2019. To ensure a fair comparison, researchers carefully matched participants who shared similar characteristics, including age, gender, medical history, existing health conditions, and general lifestyle habits.

That matching process produced a balanced group of 32,316 participants, who were then divided into two categories:

• Complete quitters who stopped using all nicotine products
• Switchers who transitioned to smokeless nicotine products such as vapes

The researchers followed these participants for an average of 4.6 years to see whether they developed eye conditions, including cataracts, glaucoma, age-related macular degeneration, diabetic retinopathy, and focus-related eyesight disorders.

The Key Findings

Over the tracking period, the study recorded a total of 6,328 major eye disease events. The results pointed to a clear divide between those who quit entirely and those who switched.

People who quit nicotine completely had the lowest disease rate, at 41.1 cases per 1,000 person-years, a measure that accounts for both the number of people studied and how long they were followed. By comparison, that rate rose to 44 cases among those who switched to smokeless alternatives like vapes.

Overall, the data showed that switching to alternative nicotine products carried a steady 7% increased risk of serious eye diseases compared to quitting nicotine entirely.

A Notable Risk for Diabetic Retinopathy

The most striking finding involved one condition in particular. Those who switched to vapes faced a 24% higher risk of developing diabetic retinopathy, a condition that damages the blood vessels in the light-sensitive tissue at the back of the eye.

In addition, switchers had a 7% higher risk of developing refractive and accommodation disorders, which affect the eye’s ability to focus clearly. Summing up the implications, the researchers noted that these findings challenge the assumption that swapping conventional cigarettes for noncombustible nicotine or tobacco products is harmless to vision.

Important Limitations

The authors were careful to acknowledge several caveats that temper how the results should be interpreted. Because the study looked back at existing health insurance data, it cannot definitively prove that vaping directly causes eye damage; it can only identify an association.

The research also relied on participants filling out questionnaires about their own smoking and vaping habits. Self-reported data of this kind can sometimes lead to underreporting or simple memory errors, which may affect the accuracy of the findings.

The Bottom Line

This study adds to a growing body of research questioning the assumption that switching to vapes is a clean bill of health. While the increased risks identified were modest in some categories and more pronounced for diabetic retinopathy, the overall message is that quitting nicotine entirely appeared to offer the best outcome for eye health in this large population. Still, given the study’s limitations, more research will be needed to confirm whether vaping truly causes these conditions.

Anyone weighing options for quitting smoking or vaping, or concerned about their eye health, should speak with a doctor or qualified healthcare provider who can offer guidance tailored to their individual circumstances.